Phase II/III Seamless Clinical Study of MG-K10 Humanized Monoclonal Antibody Injection in Treatment of Seasonal Allergic Rhinitis
Phase 2
Recruiting
- Conditions
- Seasonal Allergic Rhinitis
- Interventions
- Biological: MG-K10 Humanized Monoclonal Antibody InjectionBiological: Placebo
- First Posted Date
- 2025-02-26
- Last Posted Date
- 2025-04-18
- Lead Sponsor
- Shanghai Mabgeek Biotech.Co.Ltd
- Target Recruit Count
- 160
- Registration Number
- NCT06846385
- Locations
- 🇨🇳
Beijing Tongren Hospital, Capital Medical University, Beijing, Beijing, China
Clinical Trial of MG-K10 in Stage III of Moderate to Severe Asthma
Phase 3
Recruiting
- Conditions
- Asthma
- Interventions
- Drug: MG-K10/Placebo
- First Posted Date
- 2025-02-20
- Last Posted Date
- 2025-04-17
- Lead Sponsor
- Shanghai Mabgeek Biotech.Co.Ltd
- Target Recruit Count
- 504
- Registration Number
- NCT06837922
- Locations
- 🇨🇳
The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China
Phase III Clinical Study of MG-K10 Humanized Mab Injection in Subjects With Prurigo Nodularis
Phase 3
Recruiting
- Conditions
- Prurigo Nodularis
- Interventions
- Drug: Placebo
- First Posted Date
- 2025-01-16
- Last Posted Date
- 2025-04-18
- Lead Sponsor
- Shanghai Mabgeek Biotech.Co.Ltd
- Target Recruit Count
- 160
- Registration Number
- NCT06779136
- Locations
- 🇨🇳
Peking University People's Hospital, Beijing,, Beijing, bejing, China
IB/IIa Study of MG-K10 in Adolescent Moderately Severe Patients
- First Posted Date
- 2025-01-09
- Last Posted Date
- 2025-01-09
- Lead Sponsor
- Shanghai Mabgeek Biotech.Co.Ltd
- Target Recruit Count
- 24
- Registration Number
- NCT06765005
- Locations
- 🇨🇳
Hangzhou First People's Hospital;, Hangzhou, Zhejiang, China
Clinical Study of MG-K10 Humanized Monoclonal Antibody Injection in Healthy Adult Subjects
Not Applicable
Active, not recruiting
- Conditions
- Pharmacokinetics
- Interventions
- Drug: MG-K10 humanized monoclonal antibody injection (prefilled syringe)Drug: MG-K10 humanized monoclonal antibody injection（Penicillin bottle）
- First Posted Date
- 2024-02-26
- Last Posted Date
- 2024-08-21
- Lead Sponsor
- Shanghai Mabgeek Biotech.Co.Ltd
- Target Recruit Count
- 60
- Registration Number
- NCT06277284
- Locations
- 🇨🇳
The Second Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China
Study of MG-K10 Humanized Monoclonal Antibody Injection in Patients With Atopic Dermatitis
Phase 3
Recruiting
- Conditions
- Atopic Dermatitis
- Interventions
- Drug: MG-K10/Placebo
- First Posted Date
- 2023-09-07
- Last Posted Date
- 2024-02-23
- Lead Sponsor
- Shanghai Mabgeek Biotech.Co.Ltd
- Target Recruit Count
- 498
- Registration Number
- NCT06026891
- Locations
- 🇨🇳
Peking University People's Hospital, Beijing, China
Single Dose Clinical Trial of MG-ZG122 in Chinese Healthy Adult Subjects
Phase 1
Active, not recruiting
- Conditions
- Asthma
- Interventions
- Drug: MG-ZG122 Humanized Monoclonal Antibody InjectionDrug: Placebo
- First Posted Date
- 2022-12-21
- Last Posted Date
- 2024-02-23
- Lead Sponsor
- Shanghai Mabgeek Biotech.Co.Ltd
- Target Recruit Count
- 34
- Registration Number
- NCT05659927
- Locations
- 🇨🇳
The Second Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China
A Study of MG-K10 in Subjects With Atopic Dermatitis
- First Posted Date
- 2022-07-20
- Last Posted Date
- 2024-02-23
- Lead Sponsor
- Shanghai Mabgeek Biotech.Co.Ltd
- Target Recruit Count
- 163
- Registration Number
- NCT05466877
- Locations
- 🇨🇳
Huashan Hospital Affiliated to Fudan University, Shanghai, China
🇨🇳The First Affiliated Hospital of Bengbu Medical College, Bengbu, China
A Study of MG-K10 in Subjects With Asthma
- First Posted Date
- 2022-05-19
- Last Posted Date
- 2023-08-21
- Lead Sponsor
- Shanghai Mabgeek Biotech.Co.Ltd
- Target Recruit Count
- 180
- Registration Number
- NCT05382910
- Locations
- 🇨🇳
The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China
© Copyright 2025. All Rights Reserved by MedPath